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A B S T R A C T
Consumption of diets high in fat and/or fructose content promotes tissue inflammation, oxidative stress, and
insulin resistance, activating signals (e.g. NF-κB/JNK) that downregulate the insulin cascade. Current evidence
supports the concept that select flavonoids can mitigate obesity and type 2 diabetes (T2D). This work in-
vestigated if supplementation with the anthocyanidins (AC) cyanidin and delphinidin could attenuate the ad-
verse consequences of consuming a high fat diet (HFD) in mice. Consumption of an AC-rich blend mitigated
HFD-induced obesity, dyslipidemia and insulin resistance (impaired responses to insulin and glucose). HFD-fed
mice were characterized by increased liver lipid deposition and inflammation, which were also attenuated upon
AC supplementation. HFD caused liver oxidative stress showing an increased expression of NADPH oxidases,
generators of superoxide and H2O2, and high levels of oxidized lipid-protein adducts. This was associated with
the activation of the redox sensitive signals IKK/NF-κB and JNK1/2, and increased expression of the NF-κB-
regulated PTP1B phosphatase, all known inhibitors of the insulin pathway. In agreement with an improved
insulin sensitivity, AC supplementation inhibited oxidative stress, NF-κB and JNK activation, and PTP1B over-
expression. Thus, cyanidin and delphinidin consumption either through diet or by supplementation could be a
positive strategy to control the adverse effects of Western style diets, including overweight, obesity, and T2D.
Modulation of inflammation, oxidative stress, and NF-κB/JNK activation emerge as relevant targets of AC
beneficial actions.
1. Introduction
Overweight and obesity put individuals at risk of major health
problems including type 2 diabetes (T2D), nonalcoholic fatty liver
disease (NAFLD) and cardiovascular disease. Consumption of Western
style diets can be a major contributing factor to the increased rates of
overweight and obesity in human populations, while consumption of
select fruits and vegetables could attenuate these conditions. Evidence
for the latter is conflicting when considering overall intakes, types of
fruits and vegetables consumed, and other variables associated with
population studies [1–3]. On the other hand, a large body of evidence in
experimental animals suggests a benefit of select phytochemicals pre-
sent in fruits and vegetables in the development of obesity and asso-
ciated pathologies triggered by consumption of high fructose and/or
high fat diets.
Among phytochemicals, anthocyanidins (AC) are flavonoids being
actively investigated for their potential to mitigate unhealthy condi-
tions, particularly metabolic disorders. In this regard, mounting evi-
dence supports a potential beneficial action of AC consumption on T2D
[4] and cardiovascular health [5]. Furthermore, AC-rich food
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consumption is inversely correlated with overall mortality [6]. AC are
flavonoids that exist in nature as anthocyanins, the glycosylated forms
of AC. They provide color to grapes, berries, blueberries, black currants,
bilberries, purple corn, and black rice, among other fruits and vege-
tables. With the basic three-ring structure of flavonoids, AC are char-
acterized by double bonds in the three rings and a positive charge in the
B ring on the oxygen atom [7]. Different hydroxyl substitutions in
number and position define different AC, e.g. delphinidins, malvidins,
and peonidins. These differences in substitutions can have a major
impact on AC biological actions in animals. In this regard, we recently
observed that 3-O-glucosides of cyanidin and delphinidin were more
efficient than malvidin, petunidin and peonidin 3-O-glucosides at in-
hibiting tumor necrosis factor alpha (TNFα)-induced activation of
transcription factor NF-κB in Caco-2 cells [8].
Dietary energy overload can cause tissue inflammation, oxidative
stress, and insulin resistance. Excess fat consumption leads to the ac-
tivation of inflammatory and redox-regulated events including: i) the
IκB kinase (IKK), and downstream the transcription factor NF-κB; and
ii) the mitogen activated kinase c-jun N-terminal kinase (JNK).
Activation of both JNK [9,10] and IKK [11] and the increased expres-
sion of the NF-κB-regulated protein tyrosine phosphatase 1B phospha-
tase (PTP1B) [12] downregulate the insulin signaling pathway leading
to insulin resistance. Inflammation, oxidative stress, and chronic NF-κB
activation also contribute to other major adverse consequences of
obesity, e.g. NAFLD and cardiovascular disease [13–15].
Identifying fruits and vegetables and their active components that
can provide protection against the adverse effects of consuming
Western style diets has the potential to have a major impact on human
health. Moreover, understanding the mechanisms by which these
components act modifying cell functions is crucial to define public re-
commendations in terms of diets and potential supplementation. This
work investigated the capacity of a diet enriched in the AC cyanidin and
delphinidin to mitigate in mice the development of obesity, dyslipi-
demia, steatosis, and insulin resistance promoted by the chronic con-
sumption of a HFD. The beneficial effects of AC were mainly associated
with the attenuation of liver inflammation, oxidative stress, and
downregulation of the redox sensitive JNK and IKK/NF-κB. These
findings stress the concept that cyanidins and delphinidins can provide
benefits against excess fat consumption and its adverse health con-
sequences.
2. Materials and methods
2.1. Materials
Cholesterol and triglyceride concentrations were determined using
kits purchased from Wiener Lab Group (Rosario, Argentina). Glucose
levels were measured using a kit purchased from Sigma-Aldrich Co (St.
Louis, MO). Concentrations of insulin, glucagon-like peptide-1 (GLP-1),
gastric inhibitory polypeptide (GIP), leptin and adiponectin were de-
termined using kits purchased from Crystal Chem Inc. (Downers Grove,
IL). Antibodies for monocyte chemoattractant protein-1 (MCP-1)
(#2029), TNFα (#11948), phospho (Ser176/180) - IKKα/β (#2697),
IKKα (#2682), JNK2 (#9258) and β-actin (#12620) were obtained
from Cell Signaling Technology (Danvers, MA). Antibodies for F4/80
(sc-25830), nitric oxide synthase 2 (NOS2) (sc-649), phospho (Thr183/
Tyr185) - JNK (sc-6254) and NOX3 (sc-67005) were from Santa Cruz
Biotechnology (Santa Cruz, CA). Antibodies for 4-hydroxynonenal (4-
HNE) (ab46545), NOX4 (ab133303) and gp91phox (ab129068) were
from Abcam, Inc. (Cambridge, MA). The antibody for PTP1B (ABS40)
was from EMD Millipore (Hayward, CA). PVDF membranes were ob-
tained from BIO-RAD (Hercules, CA). The Enhanced chemilumines-
cence (ECL) Western blotting system was from Thermo Fisher Scientific
Inc. (Piscataway, NJ). All other chemicals were purchased from Sigma-
Aldrich Co (St. Louis, MO). The AC-rich blend was provided by NSE
Products, Inc. (Provo, UT) and its composition is shown in
Supplemental Table 1.
2.2. Determination of AC blend composition
The AC-rich blend was analyzed using a liquid chromatography
method [16,17] as previously described [8]. Briefly, the blend was
dissolved in water, filtered through PTFE (0.22 µm) membranes and
separations performed using an Agilent series 1200 instrument (Agilent
Technologies, Santa Clara, CA) with a Kinetex F5 pentafluorophenyl
HPLC column (2.6 µm, 100×4.6mm) and SecurityGuard® cartridge
(PFP, 4.0× 2.0 mm) (Phenomenex, Torrance, CA). A flow rate of
0.70ml/min and a column temperature of 37 °C was set. The injector
temperature was 4 °C with an injection volume of 7μ l. Detection was
done by UV–Vis DAD (wavelength monitored at 280 and 520 nm) and
ESI-MS-MS for mass spectral results. Quantification was based on DAD
peak area absorbance at 520 nm. A binary gradient was employed
consisting of 1.0% formic acid (v/v) in water (mobile phase A) and
1.0% formic acid (v/v) in acetonitrile (mobile phase B). Gradient was as
follows: 1% B at 0min, 7.5% B at 7min, 7.6% B at 14min, 10% B at
17min, 12% B at 18.5 min, 30% B at 24min, 90% B at 25min, 1% B at
26–30min. Mass spectral data were acquired using an Agilent 6430
triple-quadrupole mass spectrometer with electrospray injection (Agi-
lent Technologies, Santa Clara, CA, USA) set to scan mode with the
following optimal MS/MS source parameters: nebulizer at 40 psi, ca-
pillary voltage +4000 V (or − 3500 V), gas temperature 325 °C, and
flow of 5 l/min. Sheath gas was 250 °C and sheath flow of 11 l/min. AC
were identified after ionization in their molecular cation form under MS
positive ion mode. Parent ions (m/z) were previously described [8].
2.3. Animals and animal care
All procedures were in agreement with standards for care of la-
boratory animals as outlined in the NIH Guide for the Care and Use of
Laboratory Animals; experimental protocols were approved before
Table 1
Polyphenol composition of the AC-rich blend.
Compounds mg/g dry weight extract
Anthocyanidins Cyanidin 95
Delphinidin 40
Peonidin 8
Malvidin ND
Petunidin ND
Pelargonidin ND
Benzoic acids 3-methylgallate ND
4-hydroxybenzoic acid ND
Ferulic acid 0.1
Fumaric acid ND
Gallic acid 0.8
Protocatechuic acid 14.9
Quinic acid < 0.02
Shikimic acid ND
Syringic acid < 0.02
Vanillic acid 0.4
Hydroxycinnamates Caffeic acid 1.0
Chlorogenic acid 7.5
p-Coumaric 3.4
Sinapinic acid 0.7
Flavonols Kaempferol-3-galactose ND
Kaempferol-3-glucose 3.4
Kaempferol < 0.05
Naringenin < 0.05
Quercetin 0.1
Quercetin-3-galactose 1.2
Quercetin-3-Rutin 0.1
catechins Catechin ND
Epicatechin < 0.001
Gallocatechins ND
ND: Not detected.
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implementation by the University of California, Davis Animal Use and
Care Administrative Advisory Committee. Procedures were adminis-
tered under the auspices of the Animal Resource Services of the
University of California, Davis.
Healthy male C57BL/6J mice (20–25 g) (10 mice/group) were fed
for 14 w either: i) a diet containing approximately 10% total calories
from fat (Control, C group); ii) the control diet plus 40mg AC/kg body
weight (CA group); iii) a diet containing approximately 60% total cal-
ories from fat (lard) (HF group); or iv) the high fat diet supplemented
with 2 (HFA2 group), 20 (HFA20 group) or 40 (HFA40 group) mg AC/
kg body weight.
Body and food intake were measured weekly throughout the study.
After 14 w on the dietary treatments, mice were euthanized by cervical
dislocation, blood was collected from the sub-mandibular vein into
heparinized tubes, and plasma was obtained after centrifugation at
1000×g for 15min at 4 °C. Different adipose tissue pads, and liver were
collected and weighed. Tissues were flash frozen in liquid nitrogen and
then stored at − 80 °C for further analysis.
2.4. Metabolic measurements
For insulin tolerance tests (ITT), mice were fasted for 4 h and in-
jected i.p. with 1 U human insulin/kg body weight. Blood glucose va-
lues were measured before and at 15, 30, 45, 60, 90 and 120min post-
injection. For glucose tolerance tests (GTT), overnight fasted mice were
injected with D-glucose (2 g/kg body weight), and blood glucose was
measured before and at 15, 30, 60, and 120min post-injection. For both
tests, glucose levels were measured using a glucometer (Easy Plus II,
Home Aid Diagnostics Inc, Deerfield Beach, FL). At the end of the study,
plasma total cholesterol, triglycerides, glucose, insulin, adiponectin,
leptin, GLP-1 and GIP concentrations were determined following
manufacturer's guidelines.
2.5. Determination of fecal and liver triglyceride content
Fecal triglyceride content was measured using a modified method to
that proposed by Folch et al. [18]. Fecal samples were collected over
24 h from single cages (3–4 mice) and dried at 37 °C for 24 h. Dried
feces (0.5 g) were ground to a fine powder using a mortar and pestle.
The lipid extraction was performed by homogenizing the fecal powder
with 500ml of chloroform-methanol (2:1, v/v) solution. Samples were
mixed for 5min and centrifuged at 1000×g for 10min at room tem-
perature and the lower liquid phase containing the extracted lipids in
chloroform-methanol was collected and evaporated overnight. Analysis
of triglyceride content was performed by saponification using a method
described by Weber et al. [19] with minor modifications. Briefly, the
lipid residue was digested by incubation with 500 µl of a KOH (30% w/
v):ethanol (1:2 v:v) solution for 30min at 60 °C. An aliquot (200 µl) was
combined with 215 µl of 1M MgCl2. After centrifugation for 15min at
2000×g at room temperature, 2 µl of the supernatant were collected
and analyzed for glycerol content using the enzymatic triglyceride kit
TG Color GPO/PAP AA (Wiener Lab, Rosario, Argentina).
Analysis of liver triglyceride content was performed after extraction
and saponification, basically as previously described for feces. Briefly, a
100 µl aliquot of 10% (w/v) liver homogenate was mixed with 300 µl of
a KOH (30% w/v):ethanol (1:2, v:v) solution and evaporated overnight
at 55 °C. The following day, 1ml of 50% (v/v) ethanol was added and
samples centrifuged for 5min at 10,000×g at room temperature. Of the
resulting supernatant, 200 µl were added with 215 µl of 1M MgCl2 and
placed on ice for 10min. After centrifugation at 10,000×g for 5min at
room temperature, 10 µl of the supernatant were analyzed for trigly-
ceride content as described above.
Table 2
Metabolic parameters from mice fed for 14 w a control (Control) or a high fat diet (HF), without or with supplementation with 2, 20, or 40mg AC/kg body weight
(HFA2, HFA20, HFA40, CA40). Cholesterol, triglycerides, glucose, and insulin were measured in plasma. Values are shown as means± SE (n=10). Values having
different superscripts are significantly different (p < 0.05, one way ANOVA).
Parameter Control CA40 HF HFA2 HFA20 HFA40
Daily food intake (g/d) 3.7 ± 0.2a 4.1 ± 0.1c 3.0 ± 0.1b 3.0 ± 0.1b 2.8 ± 0.1b 2.9 ± 0.03b
Body weight (g) 33.7 ± 0.8a 35.8 ± 1.0a 44.1 ± 1.8b 41.6 ± 1.2bc 41.0 ± 1.2bc 38.1 ± 2.2c
Brown fat (mg) 149 ± 12a 213 ± 24b 259 ± 20b 204 ± 32 cd 201 ± 20 cd 178 ± 20a
Epididymal fat (g) 1.23 ± 0.10a 1.45 ± 0.15a 2.36 ± 0.10b 2.28 ± 0.21b 2.49 ± 0.09b 2.22 ± 0.29b
Visceral fat (g) 0.53 ± 0.10a 0.55 ± 0.07ac 1.28 ± 0.12b 1.02 ± 0.12b 1.16 ± 0.18b 0.89 ± 0.12c
Subcutaneous fat (g) 0.98 ± 0.06a 1.59 ± 0.19a 3.54 ± 0.23b 2.78 ± 0.36b 3.43 ± 0.27b 2.71 ± 0.49b
Retroperitoneal fat (g) 0.40 ± 0.27a 0.54 ± 0.07a 1.26 ± 0.09b 0.95 ± 0.07cb 1.25 ± 0.15b 0.84 ± 0.13c
Total cholesterol (mg/dl) 126 ± 3a 134 ± 5a 160 ± 3b 147 ± 7b 156 ± 6b 138 ± 5a
Triglycerides (mg/dl) 84 ± 2a 84 ± 2a 92 ± 1b 86 ± 2a 86 ± 3a 86 ± 2a
Fasted glucose (mg/dl) 164 ± 8a 200 ± 12a 230 ± 11b 206 ± 17b 225 ± 11b 161 ± 13a
Fasted insulin (ng/ml) 0.53 ± 0.04ac 0.47 ± 0.04c 1.22 ± 0.10b 0.88 ± 0.20a 1.08 ± 0.24b 0.61 ± 0.10ac
Fig. 1. Effects of supplementation with an AC-rich blend on metabolic
parameters in HFD-fed rats. A- Food intake and B- body weight gain. Mice
were fed a control diet (empty triangles), the control diet supplemented with
40mg AC/kg body weight (full triangles), a HFD (black circles), or the HFD
supplemented with 2 (light pink diamonds), 20 (dark pink diamonds), or 40mg
AC/kg body weight (red circles). Results are shown as means± SE and are the
average of 9–10 animals/group. Differences between the HF and HFA40 body
weight gain values are significant between weeks 4 and 14 on the diets
(p < 0.05, repeated measures ANOVA).
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2.6. Histological analyses
The liver was removed and samples fixed overnight in 4% (w/v)
neutralized paraformaldehyde solution. Samples were subsequently
washed twice in phosphate buffer saline solution, dehydrated, and then
embedded in paraffin for histological analysis. Sections (5 µm thick-
ness) were obtained from paraffin blocks and placed on glass slides.
Hematoxylin and eosin staining was performed following standard
procedures. Sections were examined using an Olympus BX51 micro-
scope (Olympus America Inc., Center Valley, PA). Hepatic histological
examination was performed using the NAFLD activity score (NAS) de-
scribed by Kleiner et al. [20]. Three randomly selected fields per animal
were assessed and analyzed using Pro Plus 5.1 software (Media Cy-
bernetics, Rockville, MD).
2.7. Western blot analysis
Livers were homogenized as previously described [21]. Aliquots of
total homogenates containing 25–40 μg protein were denatured with
Laemmli buffer, separated by reducing 7.5–12.5% polyacrylamide gel
electrophoresis, and electroblotted to PVDF membranes. Membranes
were blocked for 2 h in 5% (w/v) bovine serum albumin and subse-
quently incubated in the presence of the corresponding primary anti-
bodies (1:1000 dilution) overnight at 4 °C. After incubation for 90min
at room temperature in the presence of secondary antibodies (HRP
conjugated) (1:10,000 dilution), the conjugates were visualized using
enhanced chemiluminescence.
2.8. Electrophoretic mobility shift assay (EMSA)
NF-κB-DNA binding was assessed in the nuclear fractions obtained
from liver as previously described [22,23]. The EMSA was performed
by end labeling the oligonucleotide containing the consensus sequences
for NF-κB with [γ-32P] ATP. The oligonucleotide was end-labeled using
T4 polynucleotide kinase and purified using Chroma Spin-10 columns.
Samples were incubated with the labeled oligonucleotide
(20,000–30,000 cpm) for 20min at room temperature in 1X binding
buffer [5X binding buffer: 50mM Tris-HCl buffer, pH 7.5, containing
20% (v/v) glycerol, 5 mM MgCl2, 2.5mM EDTA, 2.5mM DTT, 250mM
NaCl, and 0.25mg/ml poly(dI-dC)]. The products were separated by
electrophoresis in a 6% (w/v) non-denaturing polyacrylamide gel using
0.5 X TBE (45mM Tris/borate, 1 mM EDTA) as the running buffer. The
gels were dried and the radioactivity quantified in a Phosphoimager
840 (Amersham Pharmacia Biotech. Inc., Piscataway, NJ).
2.9. Statistical analysis
Data were analyzed by one-way analysis of variance (ANOVA) using
Statview 5.0 (SAS Institute Inc., Cary, NC). Fisher least significance
difference test was used to examine differences between group means.
A repeated measure ANOVA with Tukey-Kramer multiple comparison
test was used to analyze changes in body weight and food intake. A P
value< 0.05 was considered statistically significant. Data are shown as
means ± SEM.
3. Results
3.1. Diets
To prepare the diets containing AC, in particular cyanidin and
delphinidin, control and high fat diets were added with a blend of berry
and black rice extracts. The polyphenol composition of the AC-rich
blend was determined as described in Methods and is shown in Table 1.
It can be estimated that the AC containing diets provided AC glycosides
Fig. 2. Effects of supplementation with an
AC-rich extract on GTT and ITT responses in
HFD-fed rats. GTT (A) and ITT (B) were per-
formed on weeks 9 and 11 on the diets, re-
spectively. Mice were fed a control diet (empty
triangles, empty bars), the control diet sup-
plemented with 40mg AC/kg body weight (full
triangles, dashed bars), a HFD (black circles,
black bars), or the HFD supplemented with 2
(light pink diamonds, light pink bars), 20 (dark
pink diamonds, dark pink bars), or 40mg AC/
kg body weight (red circles, red bars). The area
under the curve for GTT and ITT tests were
calculated, values referred to the control
group, and shown as bars in the right panels.
Results are shown as means± SE and are the
average of 9–10 animals/group. Values having
different superscripts are significantly different
(p < 0.05, one-way ANOVA).
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in the following percentages: 66% cyanidin, 28% delphinidin and 5.6%
peonidin of the total AC content.
3.2. Animal outcomes
Daily food intake in the groups fed the HFD was significantly lower
than in those fed the control and CA diets (Table 2, Fig. 1A). However,
the calorie intake was similar within groups (14.4 and 14.8 kcal/d for
control- and HFD-fed mice, respectively). Weekly food intake did not
significantly vary within groups (Fig. 1A).
Starting at week 4 and through the following weeks, the body
weight gain for C, CA, and HFA40 groups was significantly lower than
for the HF group (Fig. 1B). At week 14, there was a dose-dependent
decrease in body weight depending on the amount of AC in the diet
(Table 2). At the end of the study, consumption of the HFD caused a
31% higher body weight compared to controls, while the body weight
of HFA40 mice was 14% lower than in HF mice.
HFD-induced obesity was associated with an increased weight of the
different fat pads (brown, epididymal, visceral, subcutaneous and ret-
roperitoneal) (Table 2). HFA40 mice showed a brown fat content si-
milar to C mice, and 72% and 49% lower visceral and retroperitoneal
fat accumulation, respectively, compared to HF mice. Brown fat weight
in CA mice was 43% higher than in the C group.
Consumption of the HFD also caused dyslipidemia. Plasma choles-
terol and triglyceride levels were 26% and 9% higher in HF than in C
mice, respectively (Table 2). Supplementation of HFD-fed mice with AC
prevented the increase of plasma triglyceride concentrations at all the
AC concentrations tested, while plasma cholesterol increase was only
prevented at the highest AC supplementation level, i.e. HFA40 group.
While there were no significant differences in the amount of tri-
glycerides excreted with the feces among the control, HF and CA groups
(10.2 ± 0.8, 12.0 ± 0.3 and 12.0 ± 0.1mg/g feces, respectively),
fecal triglyceride amount in the HFA40 group (15.6 ± 3.6mg/g feces)
was significantly higher than in the control group (p < 0.04). Fecal
cholesterol content was significantly higher (p < 0.05) in the HF and
HFA40 groups (8.0 ± 0.3 and 6 ± 0.8mg/g feces, respectively) than
in control and CA groups (2.7 ± 0.1 and 3.2 ± 0.3, respectively).
3.3. Supplementation with AC improved glucose homeostasis in mice fed a
high fat diet
Fasting plasma glucose and insulin were 40% and 130% higher,
respectively, in the HF compared to the C group. In the HFA40 group,
both parameters showed values similar to those observed in the C and
CA groups, while in the HFA2 group only plasma insulin was similar to
control values (Table 2). Consumption of the HFD diet altered the re-
sponse of mice to insulin (ITT) and glucose (GTT) tolerance tests
(Fig. 2A, B). The area under the curve for the GTT and ITT was 41% and
24% higher, respectively, in HF than in C and CA mice. Supplementa-
tion with AC at the highest dose tested caused a 59% reduction of the
increase in GTT area under the curve, and total prevention of the in-
crease in ITT area under the curve. Given that supplementation with
Fig. 3. Effects of supplementation with an AC-rich blend on hormones relevant to glucose homeostasis in HFD-fed rats. A-Adiponectin, B- leptin, C- GIP and
D- GLP-1 were measured in plasma of mice fed for 14 w- a control diet (empty bars), the control diet supplemented with 40mg AC/kg body weight (dashed bars), a
HFD (black bars), or the HFD supplemented with 40mg AC/kg body weight (red bars). Results are shown as means± SE and are the average of 9–10 animals/group.
Values having different superscripts are significantly different (p < 0.05, one-way ANOVA).
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40mg AC/kg body weight was the AC level that provided the strongest
level of protection against HFD-induced insulin resistance, subsequent
experiments were focused only on the HFA40 group.
3.4. Supplementation with AC improved plasma hormone profiles
We next investigated the levels of select hormones, which are re-
levant to the regulation of glucose homeostasis, and that are produced
by the adipose tissue, i.e. adiponectin and leptin, and by gastro-
intestinal enteroendocrine cells, i.e. GIP and GLP-1. While plasma
adiponectin levels were similar among groups, plasma leptin was 4
times higher in the HF compared to the C group (Fig. 3 A, B). The
increase in leptin observed in HF mice was partially (63%) prevented in
HFA40 mice. HFD consumption caused a significant increase (83%) in
plasma GIP that was not observed in the HFA40 group (Fig. 3 C).
Plasma GLP-1 concentration was significantly higher in HF, HFA40 and
CA groups (57%, 52%, and 98%, respectively) compared to the C group
(Fig. 3 D).
3.5. Supplementation with AC attenuated steatosis and inflammation in the
liver of mice fed a high fat diet
Consumption of the HFD caused steatosis and liver inflammation.
Liver triglyceride levels were 76% higher in the HFD-fed compared to
the C group. This increase in liver triglycerides was not observed in the
HFA40 group. (Fig. 4A). Lipid deposition was also assessed by histo-
logical analysis after hematoxylin-eosin staining (Fig. 4B). Consump-
tion of the HFD caused an increased lipid deposition in the liver that
was not observed in HFA40 mouse liver. The NAFLD activity score
(NAS) was significantly higher (6.4 folds) in the liver from HF com-
pared to C, CA, and HFA40 mice (Fig. 4C).
Several proteins involved in the inflammatory response were mea-
sured in liver by Western blot (Fig. 4D). The chemokine MCP-1, the
cytokine TNFα, the macrophage marker F4/80, and the enzyme NOS2
were all upregulated in the liver of HF mice. Supplementation with AC
either partially (MCP-1) or fully (F4/80, TNFα, and NOS2) prevented
these increases. No significant differences were observed between C and
CA in markers of steatosis and liver inflammation.
3.6. Supplementation with AC improved parameters of oxidative stress and
redox signaling involved in insulin resistance in the liver of mice fed a high
fat diet
HFD-associated alterations in glucose homeostasis can be due to an
upregulation of NADPH oxidase (NOX) isoforms leading to hepatic
oxidative stress, and the activation of redox-sensitive signals that pro-
mote insulin resistance. Consumption of the HFD caused the upregu-
lation of liver NOX2 (gp91phox), NOX3 and NOX4 (Fig. 5). Thus,
gp91phox, NOX3 and NOX4 levels were 43%, 51% and 80% higher,
respectively, in HF compared to C mice. AC supplementation prevented
Fig. 4. Effects of supplementation with an
AC-rich blend on steatosis and hepatic in-
flammation in HFD-fed rats. Mice were fed a
control diet (empty bars), the control diet
supplemented with 40mg AC/kg body weight
(dashed bars), a HFD (black bars), or the HFD
supplemented with 40mg AC/kg body weight
(red bars). At week 14 on the corresponding
diets the following parameters were measured:
A- liver triglyceride content, B- fat liver de-
position as evaluated by hematoxylin/eosin
tissue staining, C- NAFLD activity score (NAS),
and D- proteins involved in inflammation:
MCP-1, F4/80, TNFα, and NOS2. Western blot
bands were quantified and values referred to β-
actin levels (loading control). Results for CA,
HF and HFA40 were referred to control group
values (C). Results are shown as mean± SE of
6 animals/group. Values having different su-
perscripts are significantly different
(p < 0.05, one-way ANOVA test).
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HFD-mediated upregulation of NOX3 and NOX4, but not that of
gp91phox. The increased NOXs expression was paralleled by a 40%
increase in the levels of 4-hydroxynonenal-protein adducts in HFD-fed
mice, which was prevented by AC supplementation (Fig. 5).
The phosphorylation of the redox-sensitive signals JNK (Thr183/
Tyr185) and IKK (Ser176/180) was 84% and 83% higher, respectively,
in the liver of HF compared to C mice (Fig. 6A). The increased phos-
phorylation of both JNK and IKK was not observed in HFA40 mice. In
agreement with the activation of IKK, an upstream event in the
pathway, NF-κB-DNA binding, was 52% higher in liver nuclear fractions
from HF than in C and HFA40 mice (Fig. 6B). Activation of the NF-κB
signaling pathway was associated with an increased expression of
PTP1B, which in the liver of HF mice was 31% higher than in C and
HFA40 mice (Fig. 6A).
4. Discussion
Chronic consumption of a HFD by mice led to the development of
obesity, adiposity, dyslipidemia, steatosis, liver inflammation and in-
sulin resistance. Simultaneous consumption of a diet rich in AC, i.e.
cyanidins and delphinidins, attenuated all these adverse effects. In
addition, the AC-associated improvement of inflammation, oxidative
stress, and insulin sensitivity was in part associated with their capacity
to modulate NF-κB and JNK.
Diets rich in fat and carbohydrates are in part responsible for the
increasing global burden of overweight and obesity. The dietary con-
sumption of a HFD by mice mimics the consequences of Western style
diets in humans. The amount of ACs provided are comparable in quality
and amount to that achievable through food consumption and/or ra-
tional amounts of dietary supplements in humans. We observed that
mice eating the HFD and AC gained less weight than those fed the HFD
alone, despite consuming similar amounts of calories. In line with these
results, AC at the highest amount provided, i.e. 40mg/kg body weight,
led to lower weight of brown, visceral, and retroperitoneal fat pads, but
not epididymal or subcutaneous fat, compared to the non-supplemented
Fig. 5. Effects of supplementation with an AC-rich blend on parameters of
liver oxidative stress in HFD mice. Mice were fed a control diet (empty bars),
the control diet supplemented with 40mg AC/kg body weight (dashed bars), a
HFD (black bars), or the HFD supplemented with 40mg AC/kg body weight
(red bars). At week 14 on the corresponding diets the following parameters
were measured in liver by Western blot: gp91phox, NOX3, NOX4 and HNE-
protein adducts, Bands were quantified and values referred to β-actin levels
(loading control. Results for CA, HF and HFA40 were referred to control group
values (C). Results are shown as mean± SE of 6 animals/group. Values having
different superscripts are significantly different (p < 0.05, one-way ANOVA
test).
Fig. 6. Effects of supplementation with an
AC-rich blend on redox-sensitive signals
that modulate insulin sensitivity in HFD
mice. Mice were fed a control diet (empty
bars), the control diet supplemented with
40mg AC/kg body weight (dashed bars), a
HFD (black bars), or the HFD supplemented
with 40mg AC/kg body weight (red bars). At
week 14 on the corresponding diets the fol-
lowing parameters were measured in liver: (A)
by Western blot: phosphorylation of JNK and
IKK and PTP1B levels (bands were quantified
and values referred to total protein levels (JNK,
IKK) or β-actin levels (PTP1B); B- NF-κB-DNA
binding in liver nuclear fractions measured by
EMSA. Representative EMSA images are shown
on the right panel. To assess the specific bands,
a control nuclear fraction was incubated in the
presence of a 100-fold molar excess of un-
labeled oligonucleotide containing the con-
sensus sequence for a nonspecific (N.S.)
(FOXO-1) or specific (S.) (NF-κB) transcription
factor before the binding assay. For both A and
B, results for CA, HF and HFA40 were referred
to control group values (C). Results are shown
as mean± SE of 6 animals/group. Values
having different superscripts are significantly
different (p < 0.05, one-way ANOVA test).
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HFD-fed mice. AC-mediated decrease in visceral fat is particularly re-
levant given the role of this fat pad in the development of systemic
adverse effects through the release of adipokines, growth factors and
inflammatory molecules. Thus, visceral fat accumulation is associated
with the development of metabolic syndrome [24] and associated dis-
eases, e.g., NAFLD [25] and cardiovascular disease [26]. AC supple-
mentation also attenuated the hyperlipidemia and steatosis associated
with HFD consumption. These results disagree with previous reports
that pure AC but not AC in berry extracts have the capacity to improve
dyslipidemia [27]. These differences may be related to differences in
experimental design, but stress the relevance of the overall food matrix
in AC absorption and metabolism, and subsequently on their biological
actions. Part of the mentioned effects on obesity and steatosis could be
due to the actions of AC at the gastrointestinal tract [28]. In this regard,
factors that can contribute to the capacity of AC to mitigate body
weight gain and excess tissue lipid deposition may include the mod-
ulation of GLP-1, a hormone known to reduce adiposity [29], and/or a
decreased fat absorption associated to the inhibition of pancreatic li-
pase, which is essential for dietary triglyceride absorption in the in-
testine [30]. With regard to the latter, both cyanidin and cyanidin-3,5-
diglucoside were shown to inhibit the enzyme in vitro [31]. Pancreatic
lipase inhibition would also be consistent with the current finding of
high fecal triglyceride levels in the AC-supplemented and HFD-fed
mice.
The increasing incidence of T2D worldwide has paralleled that of
overweight and obesity. As previously reported [32,33]. HFD con-
sumption by C57BL/6J mice led to insulin resistance as evidenced by
high fasted plasma glucose and insulin levels, and impaired ITT and
GTT tests. At the highest concentration tested, the AC blend improved
all these parameters. Accordingly, an AC-rich blueberry extract was
found to improve parameters of insulin sensitivity in HFD-fed mice,
although under the tested conditions the ITT and GTT were not affected
by fat consumption [34]. The above beneficial effects could be in part
related to the capacity of AC to modulate hormones that regulate dif-
ferent aspects of glucose homeostasis. Adipokines (adiponectin, leptin)
and incretins (GLP-1, GIP) contribute to the regulation of satiety and/or
glucose homeostasis. While plasma adiponectin levels were not af-
fected, plasma leptin was increased because of HFD consumption, as it
is observed in diet-induced obesity [35], The attenuation of hy-
perleptinemia by AC supplementation in HFD-fed mice may in part
reflect a decreased fat pad mass and an improved capacity to modulate
food intake and energy balance. In terms of the incretins, GIP and GLP-
1 increase insulin secretion after food consumption influencing glucose
control. Furthermore, GLP-1 promotes satiety [36] and improves basal
and postprandial lipidemia [37]. The prevention by AC of HFD-medi-
ated GIP increase may reflect AC-mediated improved capacity to reg-
ulate glucose homeostasis. While AC supplementation did not affect
HFD-mediated increase in plasma GLP-1, it increased GLP-1 plasma
levels in mice fed the control diet. Consistently with the latter, del-
phinidin was found to increase GLP-1 secretion in GLUTag cells [38].
The capacity of cyanidin and/or delphinidin to increase plasma GLP-1
may be an important mechanism underlying, in part, their anti-obesity
and anti-T2D actions. In fact, GLP-1 is a relevant therapeutic target for
the control of T2D [29].
The liver is one of the central organs in the maintenance of glucose
and lipid homeostasis. HFD consumption disrupted this homeostasis,
and in parallel caused liver fat deposition and inflammation. The co-
ordinated AC-mediated improvement of HFD-induced liver steatosis,
inflammation, and systemic insulin resistance can be explained through
the interplay among these adverse conditions. In terms of biochemical
mechanisms, inflammation, oxidative stress and the activation of NF-κB
are events that establish a self-feeding cycle that can be initiated by
excess nutrient consumption [39,40]. The capacity of AC to mitigate
HFD-triggered hepatic inflammation and NF-κB/JNK activation can be
in part due to AC capacity to modulate liver oxidative stress. AC cannot
exert direct antioxidant actions except at the gastrointestinal tract
where they can reach high enough concentrations that allow to sca-
venge oxidants at a significant extent [41]. On the other hand, in the
liver and other organs, the regulation of oxidative stress is mainly due
to indirect antioxidant actions exerted by AC, mainly their metabolites,
through the modulation of the production of superoxide anion and ni-
tric oxide [42]. In fact, we observed that AC supplementation prevented
HFD-mediated upregulation of NOX3 and NOX4, and of the pro-in-
flammatory inducible nitric oxide synthase, NOS2. AC supplementation
also prevented the high levels of 4-HNE-protein adducts in HFD-mouse
liver. Consistently, nutrient overload can cause increased formation of
4-HNE which irreversibly form adducts with macromolecules (e.g.
proteins), which can modify cell function, and contribute to T2D and
NAFLD development [43].
Inactivation of the redox sensitive transcription NF-κB can be cen-
tral to AC beneficial actions. We observed that AC supplementation
inhibited in the liver HFD-induced NF-κB activation, as evidenced by
both decreased IKK phosphorylation, and NF-κB-DNA binding.
Accordingly, we previously observed that cyanidin and delphinidin 3-
O-glucosides inhibited TNFα-induced NF-κB activation and down-
stream loss of monolayer integrity in Caco-2 intestinal cells [8]. Cya-
nidin inhibited the inflammatory response and redox imbalance (glu-
tathione decrease) triggered by TNFα in Caco-2 cells, which was
attributed in part to NF-κB inhibition and Nrf2 upregulation [44]. NF-
κB and JNK pathways are key players in the development of insulin
resistance. Activation of the NF-κB upstream kinase IKK [45] and of
JNK [9,10] leads to the phosphorylation in serine residues of the insulin
receptor substrate-1 (IRS1) causing a downregulation of the insulin
cascade. In addition, NF-κB activation also induces the transcription of
PTP1B [46], a tyrosine phosphatase which dephosphorylates and in-
activates the insulin receptor and IRS1. Thus, disruption of the high fat-
diet induced cycle of inflammation, oxidative stress and NF-κB/JNK
activation can be central in the capacity of AC to mitigate HFD-induced
insulin resistance. Furthermore, it can be argued that the effects of AC
on insulin resistance are in part derived from an upstream regulation of
oxidant levels and/or inflammation.
In summary, supplementation with a cyanidin and delphinidin-rich
blend, mitigated the adverse consequences of HFD consumption, i.e.
obesity, dyslipidemia, steatosis, and insulin resistance. Inhibition of
inflammation, oxidative stress and NF-κB/JNK activation emerge as
mechanisms underlying those AC-mediated benefits. In addition, AC
could also act in part by inhibiting pancreatic lipase and subsequently
dietary lipid absorption, and by modulating incretins involved in glu-
cose and lipid homeostasis. Increased AC cyanidin/delphinidin con-
sumption either through diet or by supplementation could be a plau-
sible strategy to control the adverse effects of Western style diets.
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